Danish registries identified 81,361 adults with newly diagnosed type 2 diabetes and cardiovascular disease, and tracked who started SGLT2 inhibitors or GLP-1 receptor agonists. Starting rates rose with education, but that difference disappeared once other differences between people were allowed for. Unemployed men and women started at 0.77 and 0.81 times the rate of the employed, with retired, divorced, widowed and unmarried people also lower.
Why it is interesting: Who starts guideline-recommended cardioprotective drugs tracks employment and marital status rather than education.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.